Bacillus Coagulans Market REPORT OVERVIEW
-
Request Free Sample PDF to learn more about this report
The global bacillus coagulans market size was USD 92 million in 2022 and market is projected to touch USD 186.45 million by 2031, exhibiting a Compound annual growth rate (CAGR) of 8.1% during the forecast period.
Bacillus coagulans is basically a lactic acid-forming and spore-forming bacterial species within the genus Bacillus. Bacillus coagulans, shortly termed as, “B. coagulans”, is a type of probiotic that means "good" bacteria. These days, it is exclusively being used in probiotic industries for its probiotic nature and in cosmetic industries for its benefits against notorious skin problems like acne, darkheads, and others. Probiotics are used to prevent the growth of harmful bacteria in the stomach and intestines. The bacillus coagulans bacteria on consumption is known to have a healthy impact on our immune system and it also states to improve gut health and slow the onset of stomach and digestive disorders.
This bacterium is also used in several other fields like such as bakery, confectionery, dairy, beverages, functional food, and animal feed. It is increasingly used in various therapeutic treatments like diarrhea, constipation, digestive problems, lactose intolerance, and immunity enhancement. Since it produces lactic acid, it is commonly misclassified as lactobacillus. Even after having so many benefits, medicinal use of this product has not been approved by the FDA meaning that it is not sure if probiotics can be taken to cure any disease or medical condition. Generally, on consumptions of this bacterium, no serious problem occurs but it is highly recommended to see a doctor if any side effects or symptoms such as severe stomach pain; fever, chills; or worsening diarrhea are experienced.
COVID-19 Impact: Disruption in Product Supply Causes Market Deformation
The healthcare industries were probably the only industrial sectors that had experienced minimal damage from the coronavirus outbreak. Surprisingly instead of facing a significant fallout due the chaos of COVID-19 pandemic, some healthcare units topped the charts owing to high demand of numerous medical equipment and products. Amidst all this, nothing stopped the disruption of work chains and supply chains because of the government imposed lockdowns and social distancing protocols. People in large numbers were forcefully removed from their jobs. Even in the post COVID-19 era, the healthcare market continues to skyrocket, evidently increasing sales and fortifying the economy with every new product launch.
LATEST TRENDS
"Increase in Demand Product Promotes Market Augmentation"
The future of bacillus coagulans market looks quite encouraging, growing at an anticipated impressive CAGR of 8% during the review period. With the increased use of bacillus coagulans in cosmetic and probiotic industries for the production of various products, are significant factors for the development of market. Furthermore, with the aid of latest technologies and researches new and more advanced products are to be introduced to the market, promising to uplift the market sales by a huge margin. Thus, enhancing market growth.
Bacillus Coagulans Market SEGMENTATION
-
Request Free Sample PDF to learn more about this report
- Based on Type
The market categorizes into Below 100 B, 100-200 B and Above 200 B.
Below 100 B is leading type of this segment.
- By Application
The market categorizes into Drugs, Food and Beverage and Supplement Products.
Drugs is the leading application of this segment.
DRIVING FACTORS
"Increasing Demand of Product in Cosmetic Industry Bolsters Market Augmentation"
Bacillus coagulans have immense benefits for managing skin problems like anti-aging issues and acne, being a significant factor the steep rise of product in cosmetic industry. New formulations and cosmetics products are being designed and launched by the cosmetic industry leaders, enhancing market growth.
"Advancement in the Probiotics Industry is Projected to Boost Market Growth "
The post COVID-19 period witnessed an increase in concern and awareness among people regarding their health, implicitly uplifting probiotics sector. Moreover, increasing occurrence of obesity and non-communicable diseases also aids the market growth. In addition, modern technical advancements and research has led to the production and launch of many new products, boosting bacillus coagulans market growth.
RESTRAINING FACTORS
"Stringent Government Protocols Regarding the Use of Probiotics Hampers Market Growth"
The strict government policies regarding the use and intake of probiotics for the good of the population, has been a major set-back for the bacillus coagulans market. An expert panel had disapproved the use of probiotics as they are meant to support or act as a dietary supplement rather than act as a cure to a disease.
Although, efforts are being made by the companies into representing probiotics in different attractive and fascinating formulations such as bars, yogurt, and flavored chewing tablets, and others in order to attract young population towards probiotics and prebiotic products, thereby increasing sales of the bacillus coagulans market.
Bacillus Coagulans Market REGIONAL INSIGHTS
-
Request Free Sample PDF to learn more about this report
"North America Rules Out the Market Owing to High Consumption Rate"
North America region rules out the bacillus coagulans market share as it holds the largest consumption place, with a consumption market share nearly 38.9% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 26.8%. One of the reasons for North America to bag first position is because it has a large number of medical and healthcare centers, owing to factors like economy advancement and such high population. Over and above, this region witnesses an excellent network with other regions of the world making all the transportation process a lot easier and efficient.North America is more than capable to get the required advertisement or promotional investment to launch any new product, overall benefiting the market expansion.
KEY INDUSTRY PLAYERS
"Key Industry Faces to Emphasis on Product Advancement"
Majority of the prominent industry faces are anticipated to direct their focus, research and knowledge towards enhancing the products status. It is no secret that healthcare sector has probably the highest chances of taking over the market both regional and global markets, owing to high demands for healthcare products and services worldwide. For bacillus coagulans market, competition is quite intense. Kerry, Sabinsa, Mitsubishi, UAS Laboratories, Synbiotech, and the other market players listed below are the leading companies of the industry, with high-end customers. To strengthen the consumer links from all over the world is another major task for the industry players, upon which suitable measure shall be taken.
List of Market Players Profiled
- Kerry (Ireland)
- Sabinsa (U.S.)
- Mitsubishi (Japan)
- UAS Laboratories (U.S.)
- Synbiotech (Taiwan)
- Syngen Biotech (China)
- Sanzyme (India)
- Microbax (India)
REPORT COVERAGE
This report thoroughly goes over the current market status, market landscape, industry growth factors, restrainers, consumer behavior. Descriptive highlights have also been given on the market tactics and all possible trends ruling the market and that have a substantial effect on the market economy. Additionally, this report promises to give an in-depth analysis on the segmentation of respective market on the basis of type, application and region. This market research reports guarantees to all the players, stakeholders, and other participants in the global bacillus coagulans market will surely gain the upper hand, using this report as a powerful resource.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 92 Million in 2022 |
Market Size Value By |
US$ 186.45 Million by 2031 |
Growth Rate |
CAGR of 8.1% from 2022 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Types & Application |
Frequently Asked Questions
-
What value is the bacillus coagulans market expected to touch by 2031?
The global bacillus coagulans market is expected to touch USD 186.45 million by 2031.
-
What CAGR is the bacillus coagulans market expected to exhibit by 2031?
The CAGR of the bacillus coagulans market is expected to be 8.1% by 2031.
-
Which are the driving factors of the bacillus coagulans market?
Increasing demand of product in cosmetic industry and advancement in the probiotics industry are the driving factors of the bacillus coagulans market.
-
Which are the top companies operating in the bacillus coagulans market?
Kerry, Sabinsa, Mitsubishi, UAS Laboratories, Synbiotech, Syngen Biotech, Sanzyme and Microbax.